Biopharma company Receptos raises $25m for drug discovery | AltAssets Private Equity News

Subscribe today

Advanced
Search

Biopharma company Receptos raises $25m for drug discovery

24 Nov 2009

Biopharmaceutical company Receptos Inc has closed a two-tranche $25m series A round of funding. Participants in the round include ARCH Venture Partners, Flagship Ventures, Lilly Ventures and Venrock.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.